INNOVUS PHARMA INC (INNV)

0.09
0.01 5.98
OTC
Prev Close 0.09
Open 0.10
Day Low/High 0.08 / 0.10
52 Wk Low/High 0.08 / 0.21
Volume 653.79K
Exchange OTC
Shares Outstanding 216.47B
Market Cap 20.13M
Div & Yield N.A. (N.A)

Latest News

Innovus Pharmaceuticals Acquires Worldwide Rights To Four Products From Boston Topicals, LLC

Innovus Pharmaceuticals Acquires Worldwide Rights To Four Products From Boston Topicals, LLC

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter and consumer care products to improve men's and women's health and...

Innovus Pharma Reports Another New Quarterly Revenue Record Of Approximately $7.4 Million For The Third Quarter 2018 And $19.2 Million For The First Nine Months Of 2018

Innovus Pharma Reports Another New Quarterly Revenue Record Of Approximately $7.4 Million For The Third Quarter 2018 And $19.2 Million For The First Nine Months Of 2018

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men's and...

Innovus Pharmaceuticals To Release Its Third Quarter 2018 Financial Results On Wednesday, November 14, 2018

Innovus Pharmaceuticals To Release Its Third Quarter 2018 Financial Results On Wednesday, November 14, 2018

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced that the Company will release its September 30, 2018 third quarter financial results on Wednesday, November 14, 2018, after the close of the U.

Innovus Pharmaceuticals Reports Preliminary Q3 2018 Sales Revenue Of $7.0 Million To $7.1 Million

Innovus Pharmaceuticals Reports Preliminary Q3 2018 Sales Revenue Of $7.0 Million To $7.1 Million

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced preliminary third quarter 2018 net revenue is estimated to be between $7.

Innovus Pharma Receives Approval For Medicare Reimbursement For Its GlucoGorx™ Blood Glucose Monitoring System And GlucoGorx™ Blood Glucose Test Strip Products

Innovus Pharma Receives Approval For Medicare Reimbursement For Its GlucoGorx™ Blood Glucose Monitoring System And GlucoGorx™ Blood Glucose Test Strip Products

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces Planned Expansion Into CBD Oil-Based Products Market

Innovus Pharma Announces Planned Expansion Into CBD Oil-Based Products Market

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Receives Approval From Amazon® To Expand Its Amazon® Stores To Japan

Innovus Pharma Receives Approval From Amazon® To Expand Its Amazon® Stores To Japan

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma To Present At H.C. Wainwright 20th Annual Global Investment Conference

Innovus Pharma To Present At H.C. Wainwright 20th Annual Global Investment Conference

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Reports New Quarterly Revenue Record Of $7.3 Million For The Second Quarter 2018 And Expands To Canadian Market

Innovus Pharma Reports New Quarterly Revenue Record Of $7.3 Million For The Second Quarter 2018 And Expands To Canadian Market

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB: INNV), today reported results for the second quarter 2018.

Innovus Pharma Signs Purchase Agreement With "Showcase - The Home Of The Hottest Trends" To Sell The Company's Apeaz® Cream For The Relief Of Arthritis Pain In Its 110 "Showcase" Retail Stores In The United States And Canada

Innovus Pharma Signs Purchase Agreement With "Showcase - The Home Of The Hottest Trends" To Sell The Company's Apeaz® Cream For The Relief Of Arthritis Pain In Its 110 "Showcase" Retail Stores In The United States And Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces Three Regulatory Filings With Health Canada For Its Products: Xyralid® Suppositories, Beyond Human® Testosterone And RecalMax™

Innovus Pharma Announces Three Regulatory Filings With Health Canada For Its Products: Xyralid® Suppositories, Beyond Human® Testosterone And RecalMax™

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharmaceuticals To Release Its Second Quarter 2018 Financial Results On Tuesday, August 14, 2018

Innovus Pharmaceuticals To Release Its Second Quarter 2018 Financial Results On Tuesday, August 14, 2018

Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB: INNV) today announced that the Company will release its June 30, 2018 second quarter financial results on Tuesday, August 14, 2018, after the close of the U.

Innovus Pharma Signs Purchase Agreement With CVS Pharmacy, Inc. To Sell Its Product Androferti® To Increase Sperm Quality In Their Newly Established In-Store Men's Clinic

Innovus Pharma Signs Purchase Agreement With CVS Pharmacy, Inc. To Sell Its Product Androferti® To Increase Sperm Quality In Their Newly Established In-Store Men's Clinic

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue Of $6.6 Million To $6.8 Million

Innovus Pharmaceuticals Reports Preliminary Q2 2018 Sales Revenue Of $6.6 Million To $6.8 Million

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced preliminary second quarter 2018 net revenue is estimated to be between $6.

Innovus Pharma Receives Approval From Amazon® To Expand Its Amazon® Stores To Europe Covering The United Kingdom, France, Germany, Spain And Italy

Innovus Pharma Receives Approval From Amazon® To Expand Its Amazon® Stores To Europe Covering The United Kingdom, France, Germany, Spain And Italy

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces The Launch Of Its Product AllerVarx™ In Canada For Allergic Rhinitis

Innovus Pharma Announces The Launch Of Its Product AllerVarx™ In Canada For Allergic Rhinitis

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces The Approval Of Its Product ProstaGorx™ In Canada For Benign Prostatic Hyperplasia ("BPH")

Innovus Pharma Announces The Approval Of Its Product ProstaGorx™ In Canada For Benign Prostatic Hyperplasia ("BPH")

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma To Exhibit Its FlutiCare® And AllerVarx™ Products At The American Thoracic Society Event In San Diego From Sunday, May 20, 2018 To Tuesday, May 22, 2018

Innovus Pharma To Exhibit Its FlutiCare® And AllerVarx™ Products At The American Thoracic Society Event In San Diego From Sunday, May 20, 2018 To Tuesday, May 22, 2018

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Announces The Launch Of Its Product Vesele® In Canada

Innovus Pharma Announces The Launch Of Its Product Vesele® In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharmaceuticals To Release Its First Quarter 2018 Financial Results On Monday, May 14, 2018

Innovus Pharmaceuticals To Release Its First Quarter 2018 Financial Results On Monday, May 14, 2018

Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCQB: INNV), today announced that the Company will release its March 31, 2018 first quarter financial results on Monday, May 14, 2018, after the close of the U.

Innovus Pharma Announces The Launch Of Its Hemorrhoid Drug Xyralid® In Canada

Innovus Pharma Announces The Launch Of Its Hemorrhoid Drug Xyralid® In Canada

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to...

Innovus Pharma Expands Its Senior Management With The Addition Of Ryan Selhorn, CPA, As Its Vice President, Chief Financial Officer

Innovus Pharma Expands Its Senior Management With The Addition Of Ryan Selhorn, CPA, As Its Vice President, Chief Financial Officer

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe...

Innovus Pharmaceuticals Reports Record Annual Revenue For Fiscal 2017 Of $8.8 Million, Preliminary Q1 2018 Revenue Of $4.3 Million To $4.4 Million And Expects To Exit 2018 Profitable

Innovus Pharmaceuticals Reports Record Annual Revenue For Fiscal 2017 Of $8.8 Million, Preliminary Q1 2018 Revenue Of $4.3 Million To $4.4 Million And Expects To Exit 2018 Profitable

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced full year 2017 net revenue of $8.

Innovus Pharmaceuticals To Release Annual 2017 Financial Results, Preliminary First Quarter 2018 Revenues And Provide Corporate Update On Monday, April 2, 2018

Innovus Pharmaceuticals To Release Annual 2017 Financial Results, Preliminary First Quarter 2018 Revenues And Provide Corporate Update On Monday, April 2, 2018

Innovus Pharmaceuticals, Inc., ("Innovus Pharma") (OTCQB: INNV), today announced that the Company will release its December 31, 2017 annual financial results, its preliminary first quarter 2018 revenues and provide a...

Innovus Pharma To Present At The Sachs BioCapital USA Forum At The New York Academy Of Sciences

Innovus Pharma To Present At The Sachs BioCapital USA Forum At The New York Academy Of Sciences

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

Innovus Pharma's AllerVarx™ Receives Commercial Approval By Health Canada For The Reduction In Symptoms Of Seasonal Allergic Rhinitis

Innovus Pharma's AllerVarx™ Receives Commercial Approval By Health Canada For The Reduction In Symptoms Of Seasonal Allergic Rhinitis

Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and...

CORRECTING and REPLACING Innovus Pharma Launches its New Brand, Logo and its Latest E-Commerce-Enhanced Content Website

CORRECTING and REPLACING Innovus Pharma Launches its New Brand, Logo and its Latest E-Commerce-Enhanced Content Website

First paragraph, second sentence should read: The new website can be found at innovuspharma.